Skip to content

View Spec Sheet

open_in_new
  1. Shop all
  2. Polyclonal

GTX70835

AVPR2 antibody

Cannot supply to this region.

SKU:
GTX70835
Additional Names:
arginine vasopressin receptor 2 , ADHR , AVPR2 , DI1 , DIR , DIR3 , NDI , V2R , AVP Receptor V2 , AVPR V2
Application:
IHC-P
Concentration:
1 mg/ml
Physical State:
Liquid
Species Reactivity:
Human
Purification:
Affinity Purified
Storage Conditions:
-20[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., 2-8[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., -20[o]C/-70[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted.
Supplier:
Genetex
Host:
Rabbit
Reactivities:
Hamster, Human, Mouse, Rabbit, Rat
Buffer:
PBS, 0.1% Sodium azide.
Immunogen:
Synthetic 20 amino acid peptide from 3rd cytoplasmic domain of human AVPR2.
Uniprot:
P30518
Synonyms:
ADHR;antidiuretic hormone receptor;AVPR V2;DI1;DIR;DIR3;NDI;NDI1;renal-type arginine vasopressin receptor;V2R;vasopressin V2 receptor
Extra Details:
This gene encodes the vasopressin receptor, type 2, also known as the V2 receptor, which belongs to the seven-transmembrane-domain G protein-coupled receptor (GPCR) superfamily, and couples to Gs thus stimulating adenylate cyclase. The subfamily that includes the V2 receptor, the V1a and V1b vasopressin receptors, the oxytocin receptor, and isotocin and mesotocin receptors in non-mammals, is well conserved, though several members signal via other G proteins. All bind similar cyclic nonapeptide hormones. The V2 receptor is expressed in the kidney tubule, predominantly in the distal convoluted tubule and collecting ducts, where its primary property is to respond to the pituitary hormone arginine vasopressin (AVP) by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism. When the function of this gene is lost, the disease Nephrogenic Diabetes Insipidus (NDI) results. The V2 receptor is also expressed outside the kidney although its tissue localization is uncertain. When these 'extrarenal receptors' are stimulated by infusion of a V2 selective agonist (dDAVP), a variety of clotting factors are released into the bloodstream. The physiologic importance of this property is not known - its absence does not appear to be detrimental in NDI patients. The gene expression has also been described in fetal lung tissue and lung cancer associated with alternative splicing. [provided by RefSeq, Jul 2008]
Shipping Conditions:
Blue Ice